Loading asset research
+8.78%
Today
Loading 1D prices…
Company profile
Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
Display currency
USD
Location
MILAN, Italy, United States
Employees
9
CIK
1838716
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| LONALeonaBio Inc. Common Stock | $32.2M | $0.00 | — | -$24.70 | -15.28% | Buy |
| QNCXQuince Therapeutics Inc. Common Stock | $30.9M | $0.00 | — | -$1.68 | -0.50% | Hold |
| ATYRaTyr Pharma Inc. Common Stock | $30.3M | $190K | -39009.47% | -$0.80 | -19.71% | Hold |
| CVMCel-Sci Corporation Common Stock | $29.7M | $0.00 | — | -$1.76 | +2.38% | Unrated |
| EVAXEvaxion A/S American Depositary Share | $29.2M | $7.5M | -102.38% | -$1.00 | -0.61% | Buy |